Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
Top Cited Papers
- 9 April 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 127, 104362
- https://doi.org/10.1016/j.jcv.2020.104362
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung InjurymBio, 2013
- Thromboxane and the thromboxane receptor in cardiovascular diseaseClinical Lipidology, 2010
- Osteonecrosis in Patients After Severe Acute Respiratory Syndrome (SARS)JCR: Journal of Clinical Rheumatology, 2010
- Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of the human FGL2 geneJournal of General Virology, 2009
- The Nucleocapsid Protein of SARS-CoV Induces Transcription of hfgl2 Prothrombinase Gene Dependent on C/EBP AlphaThe Journal of Biochemistry, 2008
- The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluationPathology, 2006
- Pulmonary artery thrombosis in a patient with severe acute respiratory syndromeHeart, 2005
- Comparative Host Gene Transcription by Microarray Analysis Early after Infection of the Huh7 Cell Line by Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus 229EJournal of Virology, 2005
- Predictive model of diagnosing probable cases of severe acute respiratory syndrome in febrile patients with exposure riskAnnals of Emergency Medicine, 2004
- Review: Infectious Diseases and Coagulation DisordersThe Journal of Infectious Diseases, 1999